Skip to content

Unwinding Anxiety for Migraine: Pilot

Unwinding Anxiety for Migraine: Pilot

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06150612
Acronym
UAM
Enrollment
24
Registered
2023-11-29
Start date
2024-01-03
Completion date
2025-01-01
Last updated
2023-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiousness, Migraine

Brief summary

This is a pilot study that aims to understand the feasibility and acceptability of a mobile health educational app plus group-based mindfulness therapy on anxiety and migraine-related disability among people with migraine.

Interventions

BEHAVIORALUnwinding Anxiety

In the Unwinding Anxiety arm, participants will receive 6 weeks of an educational app and weekly facilitated mindfulness groups.

Sponsors

Yeshiva University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 or older * Meets diagnostic criteria for migraine * Reports anxiety symptoms of 5 or more on GAD-7 * Has a smartphone

Exclusion criteria

* Under the age of 18 * Presence of suicidal ideation * Reports severe depression on PHQ-9 * Lack of group readiness

Design outcomes

Primary

MeasureTime frameDescription
Feasibility6 weeksAverage number of facilitated mindfulness group sessions attended out of 6 weekly sessions

Secondary

MeasureTime frameDescription
AcceptabilityAssessed at 6 weeks, immediately post-interventionAverage Credibility Score from the Credibility/Expectancy Questionnaire \[min = 3; max = 27; higher scores indicate higher credibility\]

Other

MeasureTime frameDescription
Change in AnxietyChange from Week 0 to Week 10Patient Reported Measurement Outcome System - Anxiety Short Form Score \[min = 37; Max = 83; higher scores indicate higher levels of anxiety symptoms\]
Change in Headache-Related DisabilityChange from Week 0 to Week 10Headache Disability Inventory Score \[min = 0; max = 100; higher scores indicate higher levels of headache-related disability\]

Countries

United States

Contacts

Primary ContactAnnie Kate Reeder, MA
AReeder@mail.yu.edu646-592-4368

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026